Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1013058452
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4205 McAuley Blvd, Ste 375
Oklahoma City, OK, 73120
Phone (405) 751-4343
Groups this clinician bills Medicare through
Medicare paid, 2024
$132K
3,974 services
Medicare patients, 2024
618
Average age 75
Drug cost, 2024
$3.2M
2,865 prescriptions
Company payments, 2025
$1,145
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Abby R Bova was code 36415 (venipuncture blood collection), 1,377 times for 367 patients. In total Abby R Bova billed 3,974 services in 16 codes, and Medicare paid $132K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,377 | 367 | $8.62 | $12K |
| 85025 Blood Count | Office | 1,189 | 316 | $7.59 | $9,023 |
| 99214 Office E&M - Established | Office | 634 | 458 | $77.62 | $49K |
| 99215 Office E&M - Established | Office | 303 | 92 | $126.62 | $38K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 244 | 101 | $11.76 | $2,869 |
| 99205 Office E&M - New | Office | 73 | 73 | $152.04 | $11K |
| 99213 Office E&M - Established | Office | 63 | 61 | $50.68 | $3,193 |
| 99232 Hospital E&M - Subsequent | Facility | 27 | 13 | $58.65 | $1,584 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 25 | 21 | $24.09 | $602 |
| 99223 Hospital E&M - Initial | Facility | 16 | 15 | $128.82 | $2,061 |
By year: 2022 $123K for 2,897 services; 2023 $129K for 3,343 services; 2024 $132K for 3,974 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,377 | 367 | $8.62 | $12K |
| 85025 Blood Count | 1,189 | 316 | $7.59 | $9,023 |
Medicare prescription drug claims, 2024
In 2024, the drug Abby R Bova prescribed most often to Medicare patients was Anastrozole, with 605 prescriptions and refills. In total Abby R Bova wrote 2,865 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 605 | 1,591 | 180 | $19K |
| Letrozole Generic | 162 | 440 | 51 | $5,042 |
| Gabapentin Generic | 136 | 202 | 26 | $1,928 |
| Exemestane Generic | 109 | 239 | 29 | $13K |
| Ibrance Palbociclib | 72 | 72 | Under 11 | $1.1M |
| Nystatin Generic | 60 | 62 | 28 | $861 |
| Hydroxyurea Generic | 59 | 94 | Under 11 | $1,339 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 56 | 134 | 15 | $1,003 |
| Citalopram Hbr Citalopram Hydrobromide | 56 | 118 | 15 | $453 |
| Omeprazole Generic | 55 | 110 | 14 | $796 |
| Ondansetron Odt Ondansetron | 54 | 54 | 35 | $916 |
| Alendronate Sodium Generic | 53 | 112 | 17 | $489 |
| Morphine Sulfate Er Morphine Sulfate | 48 | 48 | Under 11 | $1,858 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 41 | 41 | 19 | $686 |
| Metoclopramide Hcl Generic | 41 | 51 | Under 11 | $404 |
Brand drugs: - claims; generic drugs: 2,540 claims; opioid claims: 194.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abby R Bova $1,145 ($1,145 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,043.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.